Loading data for CAMLF — first visit, this takes a few seconds.

Central Asia Metals plc (CAMLF)

OTC Markets OTCPK: CAMLF · 实时价格 · USD

2.75

+0.00 (0.00%)

收盘价： Sep 04, 2026, 8:00 PM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

暂无数据

买价	2
市值	469M
营收（TTM）	276M
净利润（TTM）	-45.7M
	1.21
	-0.25
	n/a
	n/a
市净率（TTM）	1.60
市销率（TTM）	1.70
财报日期	n/a

卖价	2.65
成交量	300
20日均量	2,857
开盘价	2.47
前收盘价	2.75
日内区间	2.47 - 2.47
52周区间	1.68 - 3.59
分析师	n/a
目标价	n/a
分红	$0.21 (7.57%)
除息日	Sep 24, 2026

关于 CAMLF

Central Asia Metals plc, together with its subsidiaries, operates as a base metals producer. The company produces copper, zinc, silver, and lead minerals. It also owns a 100% interest in the Kounrad solvent extraction-electrowinning operation located near the city of Balkhash in central Kazakhstan; and in the Sasa mine located in north Macedonia. Central Asia Metals plc was incorporated in 2005 and is headquartered in London, the United Kingdom....

[阅读更多]

行业 Copper

板块 Basic Materials

上市日期 Sep 3, 2021

员工人数 717

交易所 OTC Markets OTCPK

股票代码 CAMLF

官网 https://www.centralasiametals.com

公司完整简介

财务表现

2025年，Central Asia Metals plc的营收为229.86M，较上一年的214.44M增长7.19%。净利润为-75.05M，下降-246.03%。

财务报表

财报意外

Central Asia Metals plc 已于 Invalid Date 发布季度财报：

营收为 n/a 低于预期 $0, ， NaN% 同比增长.
每股收益为低于预期 , ， NaN% 同比增长.

股价变动原因

新闻

1周前 · GuruFocus.com

Central Asia Metals PLC (CAMLF) (H1 2026) Earnings Call Highlights: Record EBITDA and Strategic ...

Central Asia Metals PLC (CAMLF) reports a 89% surge in EBITDA to $75.5 million, driven by strong commodity prices and operational improvements, while advancing its growth pipeline.

1周前 · Proactive

Central Asia Metals CEO: 'Really positive' H1 as Cygnus deal and drill assays loom

Central Asia Metals PLC (AIM:CAML, OTC:CAMLF) CEO Gavin Ferrar spoke with Proactive's Stephen Gunnion about the company's strong first-half 2026 performance, the proposed acquisition of Cygnus Metals,...

1周前 · Proactive

Faron Pharmaceuticals, Central Asia Metals, Gelion, S&U, Mila Resources, Georgina Energy

Faron Pharmaceuticals Limited (AIM:FARN) is set to start its phase IIb BEXERA trial for blood cancer drug bexmarilimab in the second half of this year. It'll test the drug in 90 patients across the US...

1周前 · Proactive

Central Asia Metals says revenue jumped 46% boosted by higher prices and higher volumes

Central Asia Metals PLC (AIM:CAML, OTC:CAMLF) shares climbed close to 10% in Wednesday's trade after it nearly doubled first-half earnings (EBITDA) and lifted its interim dividend to 8p as higher copp...

2月前 · Simply Wall St.

Central Asia Metals (AIM:CAML) Stock Fair Value Falls After Analyst Downgrade

Central Asia Metals is under fresh scrutiny after the stock’s fair value estimate was revised from £2.20 to £1.82, a change of about 17% that reshapes how some investors may look at its potential. Ana...

第 1 页，共 2 页

Central Asia Metals plc (CAMLF)